朗诗绿色集团(00106.HK)附属斥7.4亿人币增持一项目公司股份
朗诗绿色集团(00106.HK)公布,间接全资附属南京朗铭及南京旭博辉与中城基金订立协议,中城基金将退出对项目公司的投资,有条件同意向南京旭博辉出售所持有的标的股权及标的债权,总代价为7.44亿元人民币。
集团於中城基金之总股权为50%,分别由南京朗铭持有49.85%有限合夥权及上海朗青持有0.15%普通合夥权。余下分别由中城勇逸持有49.85%有限合夥权及中城年代持有0.15%普通合夥权。
此前,项目公司由皖新集团、中城基金及南京旭博辉分别持有51%、48%及1%的股权,完成标的股权转让後,项目公司将由南京旭博辉及皖新集团分别拥有49%及51%的股权。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.